It’s still a 40% improvement over the placebo. Also, we don’t yet have the data for duration. This report only covered the one primary outcome for the trial.
Finally, we aren’t looking for breakthrough therapy designation; we are looking for a BP partner who is in a position to more strongly advocate for a BTD. There is nothing out there other than ice cubes.
Market Data 
Markets 
AI
